REPROCELL will be attending BIO-EUROPE from the 25 – 28 October and Clinical Trials Europe 2021 from the 2 - 4 November. Book a meeting with our experts.

REPROCELL Webinars

Online webinars hosted by REPROCELL.



Review of current regulatory issues on ancillary materials and importance of animal origin free products

Dr. Takuya Matsumoto • Institute for BioScience at Ajinomoto Co. Inc. Japan

CRISPR-SNIPER Gene Editing for Challenging Cases

Dr. Tsukasa Sugo • CEO and Founder of GenAhead Bio in Fujisawa, Japan

Services and Resources for COVID-19 Research

Prof. Anne Dickinson • Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman • Chief Technical Officer, REPROCELL BioServe, USA

The Development and Application of Advanced Cell Culture Techniques to Construct Models of Human Tissues

Prof. Stefan Przyborski CSO, REPROCELL Europe / Professor in Cell Technology, Durham University, UK

Providing Safety Testing Solutions for the Pharmaceutical and Cosmetic Industry

Dr. Shaheda Ahmed • Scientific Manager, Alcyomics Ltd. UK

How Pharma is using Fresh Human Tissues to Better Predict Drug Safety and Efficacy

David Bunton • CEO REPROCELL Europe (founder of Biopta Ltd. now part of REPROCELL) UK

CRISPR/Cas9 using SNIPER Technology—Managing Challenging Cases

Dr. Tsukasa Sugo • CEO and Founder of GenAhead Bio in Fujisawa, Japan